Robert E. Hoffman - 30 Aug 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (HURA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTRA	Options (Right to Buy)	Award	$0	+23,142		$0.000000	23,142	30 Aug 2023	Common Stock	23,142	$4.66	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 25% of the options vest on August 30, 2024, with the remaining shares vesting in 36 equal monthly installments commencing on September 30, 2024.